RG 6289
Alternative Names: RG-6289Latest Information Update: 23 Feb 2024
At a glance
- Originator Roche
- Class Antidementias
- Mechanism of Action Amyloid precursor protein secretase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Alzheimer's disease